Search

everythinglearnresearchcommunity

for

Search:↓

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Mesotherapy might be a useful addition to dental surgery to reduce drug use and side effects, but more research is needed.

Injecting hyaluronidase into the artery is effective for treating skin death and hair loss caused by hyaluronic acid fillers.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Injecting triamcinolone acetonide near surgical cuts doesn't greatly affect wound healing but may help in areas with less tension.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Athletes need effective management of skin disorders for their performance and well-being.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

More research is needed to find the best long-term treatments for Alopecia Areata.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.